Xxera/openscience/retractions

Record #52748

A novel therapeutic strategy of combined camrelizumab and apatinib for the treatment of advanced hepatocellular carcinoma

Qing Yang, Gengyu Li, Xiaoqiu Wu, Haiying Lin, Wanrui Wu, Xiangpang Xie, Yu Zhu, Wei Cai, Changsheng Shi, Shengye Zhuo

Journal

Frontiers in Oncology

Publisher

Original paper date

Mar 29, 2023

Original DOI

10.3389/fonc.2023.1136366

Country

Institution

Department of Gastroenterology, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China · Interventional vascular Surgery, The Third Affiliated Hospital of Wenzhou Medical University, Wenzhou, Zhejiang, China

Open access

No

Article type

Broad categories

(HSC) Medicine - Gastroenterology (HSC) Medicine - Oncology (HSC) Medicine - Pharmacology

Citation lifecycle

How this paper is being cited

Pre-retraction

2

Same day

0

Post-retraction

1

% post-retraction

33.3%

~2.2 citations/yr before retraction · ~0.4 citations/yr after

— citing papers

Who is still citing this work

Loading…